Attorney & Managing Member
CurrentOffering a broad perspective on the challenges that face large and small, US and international clients throughout the product life-cycle when commercializing medical devices, in vitro diagnostic, digital health technology, and clinical decision support software (including AI/ML-based systems and cutting-edge technologies like AR/VR)--from handling legal and regulatory policy matters to developing regulatory strategies and market authorization support to implementing and remediating quality systems for post-market compliance. Typical client engagements include:* Supporting new product planning* Developing pre-clinical and clinical research strategies* Building, auditing, and improving quality management systems (consistent with ISO 9001:2015, ISO 13485:2016, 21 C.F.R. Part 820, ISO 14971:2019, and IEC 62304:2006/A1:2015)* Performing process and resource mapping and improvement assessments* Advising on CAPA, complaint handling, and MDR/adverse event reporting best practices* Drafting and advising on supplier/quality agreements* Developing and managing premarket regulatory strategies* Drafting and advising on premarket submissions (e.g., IDEs, Q-Subs, 513(g)s, 510(k)s, De Novo Requests, PMAs)* Conducting comprehensive and targeted quality system audits and gap assessments* Drafting FDA Form 483 and Warning Letter responses and remediation plans* Conducting and auditing 483 and Warning Letter remediation plans* Evaluating promotional materials compliance* Serving as US agent to the FDA on behalf of foreign manufacturers* Advising on import/export regulations for medical devices* Assessing post-market fraud and abuse risk and conformance to ethical standards (i.e., Codes of Conduct and OIG Compliance Guidelines)* Conducting benchmarking studies* Supporting post-acquisition integration activities* Developing and advocating for regulatory policy